TITLE

Contents of a package insert

PUB. DATE
March 2008
SOURCE
Pharmaceutical Representative;Mar2008, Vol. 38 Issue 3, p37
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the contents of the package insert, a document provided along with a prescription medication to provide additional information about the drug. The package insert offers information about the drug's description, clinical pharmacology, indications and usage. It also includes facts involving the effects of overdosing, precautions and adverse reactions.
ACCESSION #
31184204

 

Related Articles

  • Safety labeling updates & new warnings.  // Formulary;Apr2007, Vol. 42 Issue 4, p218 

    The article reports developments related to safety labeling of drugs through boxed warnings. The U.S. Food & Drug Administration (FDA) has requested for it as an addition to the prescribing information of erythropoiesis-stimulating agents. The FDA has also requested the manufacturer of...

  • Controlled substances now require security.  // Drug Store News;7/20/98, Vol. 20 Issue 11, pCP31 

    Focuses on a state policy that requires written prescriptions for controlled substances in Kentucky to be written on paper with security features.

  • EC warning on children's prescriptions.  // Pulse;4/15/2002, Vol. 62 Issue 15, p4 

    Focuses on the risk of prescribing off-label drugs to children in Europe and Great Britain according to a report released by the European Commission. Details of the report; Risk factors of a drug's adverse reactions or ineffective treatment.

  • Independent drug bulletins to promote the prescription of appropriate drugs: a necessary but difficult task. Burnand, Bernard // Bulletin of the World Health Organization;Jun2013, Vol. 91 Issue 6, p391 

    The author reflects on independent drug bulletins to promote the prescription of appropriate drugs. He suggests that prescribing physicians need a source of information about drug effectiveness which is objective and that truly independent drug bulletins are such a source. He argues that there...

  • Drugs: Dos and don'ts. Gulhati, Chandra M. // Prevention India;Apr2011, p3 

    The article discusses several 'Schedule H' labelled drugs or medicines that should not be taken without doctor's advice since they can do more harm than good when taken inappropriately. As stated, most 'Schedule H' labelled medicines in India that are sold against prescription such as...

  • LATEBREAKERS.  // Drug Topics;3/20/2006, Vol. 150 Issue 6, p8 

    The article reports on developments on topics related to the pharmaceutical industry in the U.S. Wal-Mart Stores Inc. decided to reverse company policy and to stock the emergency contraceptive Plan B in all its pharmacies effective March 20, 2006. A new formulation of selegiline from...

  • TYPICAL ENTRY.  // Nurse Practitioners Prescribing Reference;Winter2010/2011, Vol. 17 Issue 4, pA.21 

    The article presents important labeling information on the most commonly prescribed drugs and formulations.

  • Pharmaceutical Coverage and Innovation Dominate Policy Agenda. Wechsler, Jill // Applied Clinical Trials;Jan2003, Vol. 12 Issue 1, p18 

    Focuses on the plans of the government to provide prescription drug coverage for Medicare beneficiaries in the U.S. Administration of programs by private insurers and pharmacy benefit managers; Approval of bioterrorism and user fee legislation by the Congress; Implementation of the malpractice...

  • Can pharma keep pace with the counterfeiters?  // Pharmaceutical Technology Europe;Jul2010, Vol. 22 Issue 7, p16 

    The article focuses on the anti-counterfeiting solutions used by pharmaceutical firms in Europe (EU). The use of watermarks, and sophisticated barcodes are some of the anti-counterfeiting solutions used by the pharmaceutical industry. However, counterfeit medicines remains a major problem due to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics